Experiment: 9COJ

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-13C NOESY aliphatic	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
2	3D 1H-13C NOESY aromatic	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
3	3D 1H-15N NOESY	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
4	2D 1H-15N HSQC	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
5	2D 1H-13C HSQC aliphatic	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
6	2D 1H-13C HSQC aromatic	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
7	3D HNCO	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
8	3D HNCA	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
9	3D HNCACB	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
10	3D CBCA(CO)NH	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
11	3D C(CO)NH	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
12	3D H(CCO)NH	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
13	3D HCCH-TOCSY	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
14	3D HCCH-TOCSY	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
15	2D HBCBCGCDHD	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600
16	2D HBCBCGCDCEHE	500 uM [U-13C; U-15N] SH3-like tandem domain of human KIN protein, 0.5 mM PMSF, 3 mM EDTA, 0.02 % v/v sodium azide, 0.33 mM 98% 2H DSS	95% H2O/5% D2O	50 mM NaPi, 100 mM NaCl mM	6.5	1 atm	298.4	Bruker AVANCE III HD 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III HD	600

NMR Refinement
Method	Details	Software
distance geometry	The structures are based on a total of 5751 restraints, 4523 are NOE-derived distance constraints, and 1228 ambiguous restraints.	ARIA

NMR Ensemble Information
Conformer Selection Criteria	structures with favorable non-bond energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CcpNmr Analysis		CCPN
2	refinement	ARIA	2.3.2	Linge, O'Donoghue and Nilges
3	structure calculation	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
4	peak picking	CcpNmr Analysis		CCPN
5	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
6	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
7	refinement	ARIA	2.3.2	Linge, O'Donoghue and Nilges

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.